Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 50943
Gene Symbol: FOXP3
FOXP3
0.050 Biomarker disease BEFREE Additionally the data presented herein suggests that splenic FoxP3- and IL-17-producing cells are involved in the chronicity of visceral leishmaniasis. 25200768 2014
Entrez Id: 3605
Gene Symbol: IL17A
IL17A
0.030 Biomarker disease BEFREE Additionally the data presented herein suggests that splenic FoxP3- and IL-17-producing cells are involved in the chronicity of visceral leishmaniasis. 25200768 2014
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.400 Biomarker disease BEFREE Additionally, most of the peptides, except P2, were found to be non-inducers of CD4+ IL-10 against both active VL as well as treated VL subjects. 29312304 2017
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.400 GeneticVariation disease BEFREE All the exons and exon-intron boundaries of IL10 were sequenced in 184 VL patients along with 172 ethnically matched controls from VL endemic region of India. 25941808 2015
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
0.370 GeneticVariation disease BEFREE Alleles rs2276631-C (P = 0.02; OR [95%CI] = 2.11 [1.16-3.86]) and rs2279015-G (P = 0.005; OR [95%CI] = 2.42 [1.33-4.41]) of SLC11A1, were associated with susceptibility to VL, whereas genotypes rs2276631 C/C (P = 0.003; OR [95%CI] = 2.65 [1.41-5.00]) and rs2279015 G/G (P = 0.018; OR [95%CI] = 2.05 [1.15-3.64]) were significantly increased in CL and VL patients, respectively. 25603101 2015
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.400 GeneticVariation disease BEFREE Analyses showed that the distribution of TNFA RFLP alleles (TNF1 and TNF2) and the TNF MSM alleles (TNFa1 to TNFa15) differed between individuals with VL and those with DTH+ phenotypes. 12438370 2002
Entrez Id: 3320
Gene Symbol: HSP90AA1
HSP90AA1
0.010 Biomarker disease BEFREE Approximately 70% of the cDNA clones identified by immunoscreening Leishmania donovani expression libraries with serum from a patient with visceral leishmaniasis (kala-azar) were found to encode the highly conserved Hsp90 and Hsp70 members of the heat shock protein family. 1537901 1992
Entrez Id: 3308
Gene Symbol: HSPA4
HSPA4
0.060 GeneticVariation disease BEFREE Approximately 70% of the cDNA clones identified by immunoscreening Leishmania donovani expression libraries with serum from a patient with visceral leishmaniasis (kala-azar) were found to encode the highly conserved Hsp90 and Hsp70 members of the heat shock protein family. 1537901 1992
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.400 GeneticVariation disease BEFREE As based on their region in the gene, some single nucleotide polymorphisms (SNP) can influence the expression of their corresponding proteins, this study aimed to investigate the association between SNP in the IL-10, IL-12, IFN-γ genes and susceptibility to VL. 30644801 2019
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.400 Biomarker disease BEFREE At VL diagnosis, co-infected patients showed higher serum levels of interferon-gamma (IFN-gamma) than matched HIV-1 controls without VL, and lower serum concentrations of IL-10 than non-immunocompromised VL controls. 9844050 1998
Entrez Id: 80380
Gene Symbol: PDCD1LG2
PDCD1LG2
0.010 Biomarker disease BEFREE Blockade of the inhibitory receptor PD-L2 led to a significant decrease in parasite burden, revealing a pathogenic role for the PD-1 pathway in chronic VL. 28103263 2017
Entrez Id: 617
Gene Symbol: BCS1L
BCS1L
0.010 Biomarker disease BEFREE Buparvaquone (BPQ), a hydroxynapthoquinone with in vitro activity in the nanomolar range, failed to clinically translate as a viable treatment for visceral leishmaniasis due to its poor oral bioavailability limited by its poor aqueous solubility (BCS Class II drug). 29762040 2018
Entrez Id: 84627
Gene Symbol: ZNF469
ZNF469
0.010 Biomarker disease BEFREE Buparvaquone (BPQ), a hydroxynapthoquinone with in vitro activity in the nanomolar range, failed to clinically translate as a viable treatment for visceral leishmaniasis due to its poor oral bioavailability limited by its poor aqueous solubility (BCS Class II drug). 29762040 2018
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.310 Biomarker disease CTD_human Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. 17404324 2007
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.400 Biomarker disease CTD_human Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. 17404324 2007
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.330 Biomarker disease CTD_human Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. 17404324 2007
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.320 Biomarker disease CTD_human Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis. 17404324 2007
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.400 Biomarker disease BEFREE Clinical trials have shown that protection against VL is associated with robust T cell responses, especially those producing IFN-γ. 29599776 2018
Entrez Id: 358
Gene Symbol: AQP1
AQP1
0.010 GeneticVariation disease BEFREE Cloning and sequencing of the AQP1 gene from both VL and PKDL isolates showed sequence variation in four of the clinical isolates. 20067981 2010
Entrez Id: 58191
Gene Symbol: CXCL16
CXCL16
0.010 Biomarker disease BEFREE Collectively, these data provide evidence that CXCL16 is part of the inflammatory response elicited by <i>L. donovani</i> LPG <i>in vitro</i> Further investigation using CXCL16 knockout mice is required to determine whether this chemokine contributes to the pathogenesis of visceral leishmaniasis and to elucidate the underlying molecular mechanisms. 30804103 2019
Entrez Id: 3565
Gene Symbol: IL4
IL4
0.100 Biomarker disease BEFREE Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis. 29953494 2018
Entrez Id: 3123
Gene Symbol: HLA-DRB1
HLA-DRB1
0.330 Biomarker disease CTD_human Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. 23291585 2013
Entrez Id: 3117
Gene Symbol: HLA-DQA1
HLA-DQA1
0.310 Biomarker disease CTD_human Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. 23291585 2013
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.030 Biomarker disease BEFREE Considering that evaluation of immunologic parameters that may be associated with this clinical scenario may help to decrease VL lethality, we evaluated whether leptin is associated with VL pathogenesis. 30913261 2019
Entrez Id: 406906
Gene Symbol: MIR122
MIR122
0.010 AlteredExpression disease BEFREE Conversely, restoration of miR-122 or Dicer1 levels in VL mouse liver increased serum cholesterol and reduced liver parasite burden. 23498953 2013